Santoni, N.; Melo, T.; Aguirre, A. R.; Veiga, D.; Souza, C. Cost-Effectiveness of Afatinib Versus Pemetrexed Plus Cisplatin, Erlotinib and Gefitinib As First Line Treatment in Patients With Locally Advanced or Metastatic Epidermal Growth Factor Receptor Mutation (EFGR+) Non-Small Cell Lung Cancer in the Brazil. JBES 2017, 9, 73-82.